国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Business / Companies

China's pharma firm launches operations in US

(Xinhua) Updated: 2014-09-04 11:20

WASHINGTON - Tasly Holding Group, a leading pharmaceutical company in China, officially launched its North American operations in the state of Maryland Wednesday as part of its "go-out" efforts to further expand its business of traditional Chinese medicine overseas.

The company, which celebrated its 20th anniversary in May, held a ribbon-cutting ceremony at its office in Rockville, Maryland, to mark the official launch of Tasly Pharmaceuticals as its North American headquarters, with about 150 guests from the Maryland state government and biotechnology and pharmaceutical companies in attendance.

"Tasly has comprehensively implemented the strategy of internationalization," Xijun Yan, chairman of Tasly, said at the ceremony. "Establishment of Tasly Pharmaceutials is one of the most important strategies that we take. We have positioned Tasly Pharmaceuticals as our overseas headquarters, with the full support provided by Tasly Group."

He said Tasly's products and services cover biopharmaceutical drugs, healthcare products, medical rehabilitation and health management, with a total revenue of $4 billion in 2013.

"I strongly believe that our natural products will contribute to reducing the Medicare cost and effectively resolving certain healthcare-related issues of the US healthcare system," Yan said.

"China has been the leader in healing for thousands of years" and Tasly's traditional Chinese medicine "is opening up a whole new chapter of Maryland's life sciences community," said Dominick Murray, Maryland's Business and Economic Development Secretary, adding that they are "excited" to have the new Chinese investment in the state, which is home to more than 500 bioscience companies.

Tasly's products have been approved by national health regulatory authorities in at least 34 countries.

Its Fufang Danshen dripping pill, a multi-herb-based treatment for stable angina pectoris, the medical term for chest pain or discomfort, is now in a phase three clinical trial in the US and several other countries.

The company said it expected the pill to be the first ever multi-herb-based and chemical-free pharmaceutical product approved by the US Food and Drug Administration.

Tasly also plans to launch Deepure, a line of nutraceuticals that are gluten-free and made without preservatives, artificial colors, flavors, sweeteners or gelatin, in the US this fall.

China's pharma firm launches operations in US

China's pharma firm launches operations in US

China opens South China Sea cruise route Glimpse of the 4th China-Eurasia Expo

Hot Topics

Editor's Picks
...
...
瑞安市| 吴堡县| 绥德县| 马龙县| 元阳县| 渑池县| 交口县| 沙湾县| 永福县| 海安县| 靖边县| 南乐县| 峨山| 县级市| 西华县| 霸州市| 桐梓县| 集贤县| 泸西县| 东港市| 罗江县| 阿拉善右旗| 松阳县| 嘉黎县| 舒兰市| 花垣县| 台东县| 台州市| 凯里市| 航空| 固镇县| 会东县| 顺义区| 弋阳县| 喜德县| 麻阳| 通化县| 通城县| 雅安市| 东城区| 宜兴市|